Wagner, N. B., Weide, B. M., Gries, M., Reith, M., Tarnanidis, K., Schuermans, V., . . . Gebhardt, C. (2019). Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies. Journal for ImmunoTherapy of Cancer, 7(1), . https://doi.org/10.1186/s40425-019-0828-1
Chicago-Zitierstil (17. Ausg.)Wagner, Nikolaus B., et al. "Tumor Microenvironment-derived S100A8/A9 Is a Novel Prognostic Biomarker for Advanced Melanoma Patients and During Immunotherapy with Anti-PD-1 Antibodies." Journal for ImmunoTherapy of Cancer 7, no. 1 (2019). https://doi.org/10.1186/s40425-019-0828-1.
MLA-Zitierstil (9. Ausg.)Wagner, Nikolaus B., et al. "Tumor Microenvironment-derived S100A8/A9 Is a Novel Prognostic Biomarker for Advanced Melanoma Patients and During Immunotherapy with Anti-PD-1 Antibodies." Journal for ImmunoTherapy of Cancer, vol. 7, no. 1, 2019, https://doi.org/10.1186/s40425-019-0828-1.